| Product NDC: | 60505-0213 | 
| Proprietary Name: | DILTZAC | 
| Non Proprietary Name: | Diltiazem Hydrochloride | 
| Active Ingredient(s): | 300 mg/1 & nbsp; Diltiazem Hydrochloride | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 60505-0213 | 
| Labeler Name: | Apotex Corp. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA076395 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20090203 | 
| Package NDC: | 60505-0213-3 | 
| Package Description: | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (60505-0213-3) | 
| NDC Code | 60505-0213-3 | 
| Proprietary Name | DILTZAC | 
| Package Description | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (60505-0213-3) | 
| Product NDC | 60505-0213 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Diltiazem Hydrochloride | 
| Dosage Form Name | CAPSULE, EXTENDED RELEASE | 
| Route Name | ORAL | 
| Start Marketing Date | 20090203 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Apotex Corp. | 
| Substance Name | DILTIAZEM HYDROCHLORIDE | 
| Strength Number | 300 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |